Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06802731

LivQ-box® Parameters in the Diagnosis of Liver Inflammation

A Multicenter Study on the Application of LivQ-box® Parameters in the Diagnosis of Liver Inflammation in Patients with Non-alcoholic Fatty Liver Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
365 (estimated)
Sponsor
Wuxi Hisky Medical Technology Co Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.

Detailed description

This study is a multi-center study that retrospectively analyzed and prospectively included 240 NAFLD patients in total who met the inclusion criteria. The laboratory, iLivTouch, and liver biopsy results were collected to evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels. In the end, cut-off values for different stages of inflammation were obtained.

Conditions

Timeline

Start date
2024-01-01
Primary completion
2025-03-31
Completion
2025-06-30
First posted
2025-01-31
Last updated
2025-01-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06802731. Inclusion in this directory is not an endorsement.

LivQ-box® Parameters in the Diagnosis of Liver Inflammation (NCT06802731) · Clinical Trials Directory